Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.
The EC has approved the extension of Stallergenes Greer’s Palforzia for the treatment of peanut allergy in toddlers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback